Moffitt Cancer Center, Department of Health Outcomes & Behavior, 12902 Magnolia Dr. Tampa, FL 33612, United States of America.
Boston University School of Medicine, 85 E. Concord St., Boston, MA 02118, United States of America.
Prev Med. 2021 Mar;144:106400. doi: 10.1016/j.ypmed.2020.106400. Epub 2021 Jan 1.
Cervical cancer screening rates in the United States are generally high, yet certain groups demonstrate disparities in screening and surveillance. Individuals at greatest risk for cervical cancer are often from marginalized or underserved groups who do not participate in regular screening for a variety of reasons. Using the Population-based Research to Optimize the Screening Process (PROSPR) Trans-Organ Conceptual Model, including concepts of individual-, provider-, facility-, system-, or policy-level factors, we provide a commentary to highlight reasons for low screening participation among subgroups in the U.S. These include racial and ethnic minorities, rural residents, sexual and gender minorities, those with limited English proficiency, those with particular religious beliefs, and various health conditions. We describe barriers and offer potential solutions for each group. In addition, we discuss cross-cutting barriers to screening including difficulty interacting with the healthcare system (limited knowledge and health literacy, lack of provider recommendation/contact), financial (cost, lack of insurance), and logistical barriers (e.g., lack of usual source of care, competing demands, scheduling issues). Solutions to address these barriers are needed to improve screening rates across all underscreened groups. Changes at state and national policy levels are needed to address health insurance coverage. Mobile screening, ensuring that interpreters are available for all visits, and targeted in reach at non-gynecological visits can further overcome barriers. Employing community outreach workers can increase community demand for screening, and patient navigators can improve adherence to both screening and follow-up diagnostic evaluation. HPV self-sampling can address multiple barriers to cervical cancer screening.
美国的宫颈癌筛查率普遍较高,但某些人群在筛查和监测方面存在差异。宫颈癌风险最高的人群通常来自边缘化或服务不足的群体,由于各种原因,他们不参加常规筛查。我们使用基于人群的研究来优化筛查流程 (PROSPR) 跨器官概念模型,包括个体、提供者、医疗机构、系统或政策层面的因素,以提供评论来强调美国亚组人群低筛查参与率的原因。这些原因包括少数族裔和少数民族、农村居民、性和性别少数群体、英语水平有限者、具有特定宗教信仰者以及各种健康状况。我们描述了每个群体的障碍,并提供了潜在的解决方案。此外,我们还讨论了筛查的交叉障碍,包括与医疗保健系统互动困难(知识和健康素养有限、缺乏提供者推荐/联系)、经济障碍(成本、缺乏保险)和后勤障碍(缺乏常规医疗服务、竞争需求、日程安排问题)。需要解决这些障碍,以提高所有未充分筛查人群的筛查率。需要在州和国家政策层面进行变革,以解决医疗保险覆盖范围问题。移动筛查、确保所有就诊都有口译员、在非妇科就诊时进行有针对性的延伸服务,可以进一步克服障碍。聘请社区外展工作者可以增加社区对筛查的需求,而患者导航员可以提高对筛查和后续诊断评估的依从性。HPV 自我采样可以解决宫颈癌筛查的多种障碍。